Detalhe da pesquisa
1.
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1): 43-69, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394770
2.
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.
Am J Hematol
; 98(6): 848-856, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880203
3.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Cancer
; 128(3): 529-535, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633671
4.
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
J Natl Compr Canc Netw
; 20(2): 106-117, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130502
5.
Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic.
J Natl Compr Canc Netw
; : 1-4, 2020 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871558
6.
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020.
J Natl Compr Canc Netw
; 18(1): 12-22, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31910384
7.
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Biol Blood Marrow Transplant
; 24(6): 1119-1124, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608957
8.
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(9): 1108-1135, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181422
9.
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(12): 1520-1541, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29223990
10.
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia.
Am J Hematol
; 97(5): E171-E173, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132678
11.
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.
J Natl Compr Canc Netw
; 14(12): 1505-1512, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956535
12.
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population.
Biol Blood Marrow Transplant
; 21(1): 89-96, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445641
13.
Chronic myelogenous leukemia, version 1.2015.
J Natl Compr Canc Netw
; 12(11): 1590-610, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361806
14.
Metabolic tumor profiling with pH, oxygen, and glucose chemosensors on a quantum dot scaffold.
Inorg Chem
; 53(4): 1900-15, 2014 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24143874
15.
Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoring.
Front Pharmacol
; 14: 1126981, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021042
16.
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab.
Transplant Cell Ther
; 29(5): 314-320, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682470
17.
Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
Transplant Cell Ther
; 29(8): 515.e1-515.e7, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182736
18.
WT1-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens.
Leuk Lymphoma
; 64(11): 1811-1821, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533373
19.
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 18(8): 1150-63, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22510384
20.
Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
Hematology
; 27(1): 785-794, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802815